EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Renal Cell Carcinoma in Native Kidney After Kidney Transplantation: A Multicenter Case Control Study With a Focus on Screening Strategy

Pierre Pommerolle, Maryam Assem, Marine Uhl, Philippe De Sousa, Dominique Guerrot, Marc Hazzan, Thierry Lobbedez, Ophélie Fourdinier, Gabriel Choukroun

Transplant International · 2025

DOI: 10.3389/ti.2025.14487 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transplant International, 2025. Verfasst von Pierre Pommerolle und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Dialysis, and Transplantation, Amiens University Hospital, Amiens, France. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Transplantation, Kidney Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma (RCC) of native kidney is more prevalent after kidney transplantation than in the general population. Risk factors and the value of screening remain unclear. We conducted a multicenter case-control study in kidney transplant recipients transplanted between 1989 and 2017. All patients with RCC were included, and two controls were matched to each case. Two centers performed annual screening (AnS group) and the other two had other strategies (OS group). A total of 125 cancers were found in 113 patients. The majority of cancers were stage T1-T2 (92.0%), 1.6% had metastasis at diagnosis and ten (9.0%) had recurrence after nephrectomy. Men [OR 2.2; IC 95% (1.2–4.4); p = 0.02] and acquired cystic kidney disease [OR 3.2; IC 95% (1.8–5.9); p < 0.01] were associated with cancer in multivariate analysis. The 10-year survival was poorer in cases (65.6% vs. 79.1%, p < 0.001). The AnS group had fewer relapses (5.0% vs. 18.2%, p = 0.02) and a lower rate of cancer-related deaths (16.0% vs. 46.1%, p = 0.04). Survival of patients with RCC is lower than in control patients. Annual screening could improve cancer prognosis, its benefit needs to be evaluated in larger studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney TransplantationKidney NeoplasmsHumansMaleFemaleMiddle AgedCase-Control StudiesAdultRisk FactorsAgedEarly Detection of CancerNeoplasm Recurrence, LocalRetrospective StudiesNephrectomy

Stichwörter der Autor:innen

kidney transplantationnative kidneyrenal cell carcinomascreeningsurvival

Autor:innen und Institutionen

  • Department of Nephrology, Dialysis, and Transplantation, Amiens University Hospital, Amiens, France.
  • MP3CV Research Unit, University of Picardie Jules Verne, Amiens, France.
  • Department of Nephrology, Tanger University Hospital, Tanger, Morocco.
  • Department of Urology and Transplantation, Amiens University Hospital, Amiens, France.
  • Department of Nephrology, Dialysis, and Transplantation, Rouen University Hospital, Rouen, France.
  • Department of Nephrology, Dialysis, and Transplantation, Lille University Hospital, Lille, France.

Zitieren

APA

Pommerolle, P., Assem, M., Uhl, M., De Sousa, P., Guerrot, D., Hazzan, M., Lobbedez, T., Fourdinier, O., & Choukroun, G. (2025). Renal Cell Carcinoma in Native Kidney After Kidney Transplantation: A Multicenter Case Control Study With a Focus on Screening Strategy. Transplant International. https://doi.org/10.3389/ti.2025.14487

Vancouver

Pommerolle P, Assem M, Uhl M, De Sousa P, Guerrot D, Hazzan M, et al. Renal Cell Carcinoma in Native Kidney After Kidney Transplantation: A Multicenter Case Control Study With a Focus on Screening Strategy. Transplant International. 2025. doi:10.3389/ti.2025.14487

BibTeX
@article{Pommerolle2025,
  author = {Pommerolle, Pierre and Assem, Maryam and Uhl, Marine and De Sousa, Philippe and Guerrot, Dominique and Hazzan, Marc and Lobbedez, Thierry and Fourdinier, Ophélie and Choukroun, Gabriel},
  title = {Renal Cell Carcinoma in Native Kidney After Kidney Transplantation: A Multicenter Case Control Study With a Focus on Screening Strategy},
  journal = {Transplant International},
  year = {2025},
  doi = {10.3389/ti.2025.14487}
}
Kostenlos starten →